Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Giacomelli

Showing results (11-20 of 368) with videos related to

Pageof 37
Sort By:
Clinical and Experimental Rheumatology|March 5, 2021
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trialPiero Ruscitti, Onorina Berardicurti, Paola Cipriani, et al.
Annals of the Rheumatic Diseases|August 12, 2017
The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren's syndromeAlessia Alunno, Francesco Carubbi, Roberto Giacomelli, et al.
Biomed Research International|December 15, 2017
Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid ArthritisAlessia Alunno, Roberto Gerli, Roberto Giacomelli, et al.
Cells|July 3, 2019
Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid ArthritisFrancesco Carubbi, Alessia Alunno, Roberto Gerli, et al.
BMC Rheumatology|March 20, 2019
Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targetsAlessia Alunno, Francesco Carubbi, Roberto Giacomelli, et al.
Rheumatology (Oxford, England)|October 6, 2018
Tailored approach to rheumatoid arthritis treatment with TNF inhibitors: where do we stand?Roberto Caporali, Veronica Codullo, Paola Cipriani, et al.
Seminars in Immunology|July 5, 2022
The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patientsPiero Ruscitti, Onorina Berardicurti, Roberto Giacomelli, et al.
Journal of Immunology Research|August 21, 2019
Inflammation and Dysmetabolism in Systemic Autoimmune DiseasesAntonella Afeltra, Antonio Abbate, Gabriele Valentini, et al.
Autoimmunity Reviews|May 8, 2020
Cytokine storm syndrome in severe COVID-19Piero Ruscitti, Onorina Berardicurti, Annamaria Iagnocco, et al.
Autoimmunity Reviews|September 17, 2020
Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectivesPaola Di Benedetto, Piero Ruscitti, Paola Cipriani, et al.
Pageof 37

Showing results (11-20 of 368) with videos related to

Sort By:
Pageof 37
Clinical and Experimental Rheumatology|March 5, 2021
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trialPiero Ruscitti, Onorina Berardicurti, Paola Cipriani, et al.
Annals of the Rheumatic Diseases|August 12, 2017
The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren's syndromeAlessia Alunno, Francesco Carubbi, Roberto Giacomelli, et al.
Biomed Research International|December 15, 2017
Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid ArthritisAlessia Alunno, Roberto Gerli, Roberto Giacomelli, et al.
Cells|July 3, 2019
Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid ArthritisFrancesco Carubbi, Alessia Alunno, Roberto Gerli, et al.
BMC Rheumatology|March 20, 2019
Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targetsAlessia Alunno, Francesco Carubbi, Roberto Giacomelli, et al.
Rheumatology (Oxford, England)|October 6, 2018
Tailored approach to rheumatoid arthritis treatment with TNF inhibitors: where do we stand?Roberto Caporali, Veronica Codullo, Paola Cipriani, et al.
Seminars in Immunology|July 5, 2022
The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patientsPiero Ruscitti, Onorina Berardicurti, Roberto Giacomelli, et al.
Journal of Immunology Research|August 21, 2019
Inflammation and Dysmetabolism in Systemic Autoimmune DiseasesAntonella Afeltra, Antonio Abbate, Gabriele Valentini, et al.
Autoimmunity Reviews|May 8, 2020
Cytokine storm syndrome in severe COVID-19Piero Ruscitti, Onorina Berardicurti, Annamaria Iagnocco, et al.
Autoimmunity Reviews|September 17, 2020
Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectivesPaola Di Benedetto, Piero Ruscitti, Paola Cipriani, et al.
Pageof 37